Fortress Biotech (FBIO) Change in Receivables (2016 - 2025)

Fortress Biotech's Change in Receivables history runs 10 years deep, the most recent figure standing at $11.8 million for Q4 2025.

• In Q4 2025, Change in Receivables rose 1674.16% year-over-year to $11.8 million; the TTM figure through Dec 2025 stood at $19.3 million (up 532.2% YoY), while the FY2025 annual figure was $19.3 million, up 532.2% from the prior year.
• Change in Receivables for Q4 2025 stood at $11.8 million, up from $2.4 million in the prior quarter.
• The five-year high for Change in Receivables was $11.8 million in Q4 2025, with the low at -$10.4 million in Q2 2023.
• The 5-year median for Change in Receivables is $54500.0 (2021), against an average of $346350.0.
• Peak annual rise in Change in Receivables reached 14170.59% in 2023, while the deepest fall reached 10538.55% in 2023.
• Fortress Biotech's Change in Receivables stood at -$8.5 million in 2021, then jumped by 99.4% to -$51000.0 in 2022, then surged by 14170.59% to $7.2 million in 2023, then sank by 110.41% to -$747000.0 in 2024, then surged by 1674.16% to $11.8 million in 2025.
• Business Quant data shows FBIO's Change in Receivables at $11.8 million in Q4 2025, $2.4 million in Q3 2025, and -$2.8 million in Q2 2025.